Abstract:Abstract Purpose Stem cell-based attempts at regenerating chronically failing heart have not met the clinical outcomes expected by experimental studies. The efficacy of cell transplant is largely dependent on the engraftment rate, which requires cells to receive an adequate blood supply. To address this issue, we propose to develop a composite tissue engineering construct made of biocompatible pre-vascularized fibrin hydrogel. The objectives of this study are to determine co-culture conditions and to optimize fabrication of fibrin hydrogels supporting generation of capillaries and cardiomyocyte activity at the same time. Materials and methods Rat primary cardiomyocytes were co-seeded with human umbilical vein endothelial cells (HUVECs) in fibrin hydrogels. Cultures were performed in 96 well plates. Cells were cultured in a mixture of medium conditioned with human dermal fibroblasts and of cardiomyocyte medium (1:1) for 8 days. To improve co-culture of the two cell types, insulin (1 μg/mL) and/or VEGF (5 ng/mL) were added 24 hours after the initial day of culture and maintained for 24 hours. The cells treated with VEGF were also treated 5 days after initial seeding with insulin and VEGF (insulin at 1 μg/mL and VEGF at 1 or 5 ng/mL). After culture, cardiomyocytes were immuno-stained for Troponin T or Connexin-43, endothelial cells for CD31, basement membrane for collagen IV. From spinning disk images, cardiomyocyte volume, contraction and total length/ branches of capillaries were measured. Results : We first determine the best conditions allowing the generation of active cardiomyocytes and the formation of a network of mature capillaries into fibrin hydrogels. We showed that cardiomyocytes volume and contraction were not influenced by the addition of VEGF or insulin. For cells treated with VEGF for 24 hours, total length and total branches of capillaries were significantly increased over other conditions without supplements (control), or with insulin alone or with VEGF. We also observed lumen formation and basement membrane deposition. Conclusions These results may provide a new model of vascularized human heart tissue for in vitro studies, displaying cardiomyocyte contractility together with lumenized capillary formation. Furthermore, our data may help overcome current obstacles toward the success of cardiac cell therapy for damaged myocardium. In such approach, endothelial capillaries will serve as structural and trophic support through inosculation with the host cardiac vasculature after epicardial graft. As a perspective of this work, and in order to improve the cardiomyocyte alignment and the development of capillaries, we will design specific PDMS mold to allow the formation of a micro-tissue. Application of human cardiac cells and implantation in in vivo model is expected. Acknowledgement/Funding ESC research grant, Fondation de l'avenir, Societe Francaise de Cardiologie, Institut Servier

Abstract 368: Ex vivo Fabrication of Heart Tissue Model With Perfusable Blood Vessels Using Cell Sheet

Design and Fabrication of Mature Engineered Pre-Cardiac Tissue Utilizing 3D Bioprinting Technology and Enzymatically Crosslinking Hydrogel

Cell Therapy and 3D Regenerative Tissue to Remodel Heart Failure

Engineering Three-Dimensional Cardiac Microtissues for Potential Drug Screening Applications.

Engineered human cardiac tissues for modeling heart diseases

Microfabrication of liver and heart tissues for drug development

P4499Development of a hydrogel-based pre-vascularized 3D cardiac patch displaying capillary network

Cardiac tissue engineering: state of the art.

Biomimetic Perfusion and Electrical Stimulation Applied in Concert Improved the Assembly of Engineered Cardiac Tissue.

Digital Light Processing 3D Printing enables High Throughput Fabrication of Human Engineered Heart Tissues for Disease Modeling

Rapid 3D Bioprinting of in Vitro Cardiac Tissue Models Using Human Embryonic Stem Cell-Derived Cardiomyocytes.

Bioreactor Design for Culturing Vascularized Engineered Tissue in Flow Conditions

Reconstruction of Tissue- engineered Cardiac Sheet in Vitro

Fabrication and Characterization of Bio-Engineered Cardiac Pseudo Tissues

Generation of bioartificial heart tissue by combining a three-dimensional gel-based cardiac construct with decellularized small intestinal submucosa

Versatile human cardiac tissues engineered with perfusable heart extracellular microenvironment for biomedical applications

Bioprinting 3D Microfibrous Scaffolds for Engineering Endothelialized Myocardium and Heart-on-a-chip.

Microfabricated perfusable cardiac biowire: a platform that mimics native cardiac bundle

Engineering Highly-Aligned Three-Dimensional (3D) Cardiac Constructs for Enhanced Myocardial Infarction Repair.

Establishing Early Functional Perfusion and Structure in Tissue Engineered Cardiac Constructs.

Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions